Peter Bross - Concepedia

Author

Peter Bross

Also Known As

P F Bross, Peter Bross, Peter F Bross, Peter F. Bross

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Peter Bross is an author at United States Food and Drug Administration.

Peter Bross

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Peter Bross, Julie Beitz, Gang Chen, PubMed	2001	861
Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma Peter Bross, Robert C. Kane, Ann T. Farrell, Clinical Cancer Research	2004	336
Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. John R. Johnson, Peter Bross, Martin H. Cohen, PubMed	2003	102
FDA Drug Approval Summaries: Fulvestrant Peter Bross, Martin H. Cohen, Grant A. Williams, The Oncologist	2002	84
Fulvestrant in postmenopausal women with advanced breast cancer. Peter Bross, Amy Baird, Gang Chen, PubMed	2003	52
FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette–Guérin–Unresponsive Non–Muscle-Invasive Bladder Cancer Laronna Colbert, Jiang Hu, Zhenzhen Xu, Clinical Cancer Research	2024	19
Drug–Diagnostic Codevelopment Strategies: FDA and Industry Dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop Lois M. Hinman, Brian B. Spear, Zenta Tsuchihashi, Pharmacogenomics	2008	17

Page 1